Centurion Patentors as of October 29, 2024

James served as Dean of Pharmaceutical Sciences at the University of Michigan and was elected to the National Academy of Medicine. In 2020, Dalton became Executive Vice President and provost at the University of Alabama.

Patent №: 12128026 (October 29, 2024) – Selective androgen receptor degrader (SARD) ligands and methods of use thereof. This invention presents novel SARD compounds based on indole, indazole, benzimidazole, and related structures, along with pharmaceutical compositions for treating conditions such as prostate hyperproliferation, prostate cancer, androgenic alopecia, Kennedy’s disease, ALS, AAA, and uterine fibroids. The compounds act by reducing levels or inhibiting the activity of androgen receptors, including full-length receptors, splice variants, and pathogenic polyglutamine mutations.

Patent №: 12133238 (October 29, 2024) – Radio-network node, wireless device and methods performed therein. Embodiments describe a method where a radio-network node schedules resources for an uplink data transmission and a feedback transmission over the same channel. The node sends a control message to the wireless device, indicating the scheduled resources for both transmissions.

He is also a director of Shenzhen DENZA New Energy Automotive Co., Ltd. and a director of BYD Charity Foundation since 2016.

Patent №: 12132182 (October 29, 2024) – Battery energy processing device and method, and vehicle. This disclosure describes a battery energy processing device and method for vehicles. The device includes a bridge arm converter linked to the battery’s electrodes, a motor winding, an energy storage device, and a controller. In a preset state, the controller manages charging and discharging to increase the battery’s temperature through internal resistance, enabling efficient battery heating.